These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8368743)

  • 1. Novel adjuvant strategies for experimental malaria and AIDS vaccines.
    Alving CR; Detrick B; Richards RL; Lewis MG; Shafferman A; Eddy GA
    Ann N Y Acad Sci; 1993 Aug; 690():265-75. PubMed ID: 8368743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of novel adjuvants and delivery systems to improve the humoral and cellular immune response to malaria vaccine candidate antigens.
    Gordon DM
    Vaccine; 1993; 11(5):591-3. PubMed ID: 8488718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIDS vaccines show promise in primates.
    Clin Infect Dis; 2001 Oct; 33(7):i-ii. PubMed ID: 11592258
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of vaccines against malaria.
    Berzins K
    Int J Immunopharmacol; 1994; 16(5-6):385-90. PubMed ID: 7927983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.
    BenMohamed L; Gras-Masse H; Tartar A; Daubersies P; Brahimi K; Bossus M; Thomas A; Druilhe P
    Eur J Immunol; 1997 May; 27(5):1242-53. PubMed ID: 9174617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomes containing monophosphoryl lipid A and QS-21 serve as an effective adjuvant for soluble circumsporozoite protein malaria vaccine FMP013.
    Genito CJ; Beck Z; Phares TW; Kalle F; Limbach KJ; Stefaniak ME; Patterson NB; Bergmann-Leitner ES; Waters NC; Matyas GR; Alving CR; Dutta S
    Vaccine; 2017 Jul; 35(31):3865-3874. PubMed ID: 28596090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
    Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity and efficacy trials in Aotus nancymai monkeys with model compounds representing parts of a 75-kD merozoite surface antigen of Plasmodium falciparum.
    Sharma P; Ruebush TK; Campbell GH; Richman SJ; Wilkins PP; Broderson JR; Ardeshir F; Gross M; Silverman C; Skinner JC
    Am J Trop Med Hyg; 1992 Jun; 46(6):691-707. PubMed ID: 1621894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muramyl peptide adjuvants for Plasmodium falciparum and Plasmodium vivax circumsporozoite vaccines in rodent model systems.
    Bathurst IC; Gibson HL; Kansopon J; Hahm BK; Hollingdale MR; Barr PJ
    Biotechnol Ther; 1992; 3(1-2):15-34. PubMed ID: 1305890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomes containing lipid A: a potent nontoxic adjuvant for a human malaria sporozoite vaccine.
    Alving CR; Richards RL
    Immunol Lett; 1990 Aug; 25(1-3):275-9. PubMed ID: 2283158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic peptides in malaria research.
    Ramasamy R
    Pept Res; 1991; 4(4):210-9. PubMed ID: 1823600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live virus shows promise as AIDS vaccine.
    Minn Med; 1993 Feb; 76(2):52. PubMed ID: 8433695
    [No Abstract]   [Full Text] [Related]  

  • 14. Challenges and strategies for AIDS vaccine development.
    Oxford JS; Frezza P; Race E
    Vaccine; 1993; 11(6):612-4. PubMed ID: 8100664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic adjuvants for modern vaccine formulations.
    Vogel FR
    Ann N Y Acad Sci; 1995 May; 754():153-60. PubMed ID: 7625649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV vaccine design: insights from live attenuated SIV vaccines.
    Koff WC; Johnson PR; Watkins DI; Burton DR; Lifson JD; Hasenkrug KJ; McDermott AB; Schultz A; Zamb TJ; Boyle R; Desrosiers RC
    Nat Immunol; 2006 Jan; 7(1):19-23. PubMed ID: 16357854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adults.
    Chichester JA; Green BJ; Jones RM; Shoji Y; Miura K; Long CA; Lee CK; Ockenhouse CF; Morin MJ; Streatfield SJ; Yusibov V
    Vaccine; 2018 Sep; 36(39):5865-5871. PubMed ID: 30126674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
    Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines. Monkey puzzles.
    Cohen J
    Science; 2002 Jun; 296(5577):2325-6. PubMed ID: 12089425
    [No Abstract]   [Full Text] [Related]  

  • 20. Monkey business over AIDS vaccine.
    Weiss R
    BMJ; 1991 Oct; 303(6807):872. PubMed ID: 1933002
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.